Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 17,558 $ 14,473
Short-term investments 44,786 37,753
Restricted cash 338 338
Other receivables 2,232 2,444
Prepaid expenses and other current assets 1,811 729
Total current assets 66,725 55,737
Property and equipment, net 3,767 3,533
Operating lease right-of-use assets 4,222 4,455
Other assets 114 277
Total assets 74,828 64,002
Current liabilities:    
Accounts payable 3,362 1,858
Accrued expenses 2,791 5,985
Current portion of operating lease liability 1,044 998
Current portion of payable to licensor 4,691 4,580
Other current liabilities 1 1
Total current liabilities 11,889 13,422
Long-term operating lease liabilities 4,046 4,402
Long-term debt 18,079
Derivative liabilities 1,005
Warrant liabilities 48,690 31,352
Total liabilities 83,709 49,176
Commitments and contingencies
Stockholders’ (deficit) equity:    
Preferred stock - $0.01 par value; authorized 2,000,000 shares; No shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively
Common stock - $0.01 par value; authorized 200,000,000 shares; 27,550,593 and 26,523,878 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 276 265
Additional paid-in capital 772,129 764,151
Accumulated deficit (781,102) (749,524)
Accumulated other comprehensive loss (184) (66)
Total stockholders’ (deficit) equity (8,881) 14,826
Total liabilities and stockholders’ equity $ 74,828 $ 64,002